Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 244

Posts Tagged ‘profile’

Company Profile for Kiosk Manufacturer Association

Posted by fidest press agency su mercoledì, 8 gennaio 2020

Welcome to KMA. We are a global, cause-based, not-for-profit organization focused on better self-service for customers and employees through kiosks and information technology (IT). The kiosk industry association leads efforts to optimize self-service engagements and engagement outcomes using information technology such as kiosks.What we do – we are people who make up the self-service industry who are interested in establishing and following common guidelines we all agree on for accessibility. We look to the U.S. Access Board and also the European standards group for our baseline.Where we come from – the Kiosk Industry Group helped establish the Kiosk Association and KI acts as professional news and marketing for the kiosk and self-service industry. KI is funded by those companies for the benefit of developers, resources and client companies interested in self-service, kiosks, thin or internet terminals and POS systems. KI distributes news about the industry and by the industry that is relevant to companies looking to utilize self-service, and companies which assist in doing just that (hardware, software and application).Our association news website, KioskIndustry.org, provides news and features on the self-service kiosk world be it McDonalds kiosks, Global Entry or the latest in interactive digital signage.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Company Profile for Resonate Blends

Posted by fidest press agency su giovedì, 19 dicembre 2019

Based in Calabasas, California, Resonate Blends, Inc. is a cannabis/hemp based holding company centered on a vertically integrated and valued-added Wellness and Lifestyle brand. The holding company’s growth strategy, supported by its new management team, is developing and acquiring the highest quality products, technology, retail and supply chain resources to optimize financial performance and assure the highest standard of quality control. The Resonate team will soon announce its luxury cannabis-based Wellness and Lifestyle family of products that offers consistent quality and unique formulations that support the Company’s commitment to clarify the user experience.Resonate’s growth strategy is to create an ecosystem of companies, investments and research that all support the Resonate System. In addition to being product brand focused, the Company will incubate and integrate synergistic companies and partners. Using the Resonate System as its lens, Resonate finds entrepreneurial companies that support its ethos. By vertically integrating these companies, Resonate is able to provide consistent product quality that yields expected results and to manage margins and profitability at scale. http://www.resonateblends.com

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Company Profile for Jasper Therapeutics, Inc

Posted by fidest press agency su giovedì, 12 dicembre 2019

Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents and therapeutics to allow for expanded use of curative hematopoietic stem cell transplants and gene therapies. Jasper Therapeutics’ lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant. For more information, please visit us at http://www.jaspertherapeutics.com.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Company Profile for Immune-Onc Therapeutics, Inc.

Posted by fidest press agency su domenica, 24 novembre 2019

Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients. The company aims to translate unique scientific insights in myeloid cell biology and immune inhibitory receptors to discover and develop first-in-class biotherapeutics that disarm immune suppression in the tumor microenvironment. Immune-Onc has a promising pipeline built upon strategic collaborations and cutting-edge research from The University of Texas, Albert Einstein College of Medicine, and Memorial Sloan Kettering Cancer Center. Its lead program, an antibody targeting LILRB4, is being developed to treat acute myeloid leukemia and other cancers. Headquartered in Palo Alto, California, Immune-Onc has assembled a diverse team with deep expertise in drug development and proven track records of success at leading biotechnology companies. For more information, please visit http://www.immune-onc.com.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Company Profile for Leaseweb USA

Posted by fidest press agency su giovedì, 21 novembre 2019

Leaseweb USA, Inc. is a subsidiary of Leaseweb. Leaseweb is a leading Infrastructure as a Service (IaaS) provider serving a worldwide portfolio of 17,500 customers ranging from SMBs to Enterprises. Services include Public Cloud, Private Cloud, Dedicated Servers, Colocation, Content Delivery Network, and Cyber Security Services supported by exceptional customer service and technical support. With more than 80,000 servers under management, Leaseweb has provided infrastructure for mission-critical websites, Internet applications, email servers, security, and storage services since 1997. The company operates 19 data centers in locations across Europe, Asia, Australia and North America, all of which are backed by a superior worldwide network with a total capacity of more than 5.5 Tbps. Leaseweb offers services through its various subsidiaries, which are Leaseweb Netherlands B.V. (“Leaseweb Netherlands”), Leaseweb USA, Inc. (“Leaseweb USA”), Leaseweb Asia Pacific PTE. LTD (“Leaseweb Asia”), Leaseweb CDN B.V. (“Leaseweb CDN”), Leaseweb Deutschland GmbH (“Leaseweb Germany”), Leaseweb Australia Ltd. and Leaseweb UK Ltd.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Company Profile for ReAlta Life Sciences, Inc.

Posted by fidest press agency su giovedì, 29 agosto 2019

ReAlta Life Sciences, Inc. is an early stage pharmaceutical company incorporated in late 2018, and located in Norfolk, Virginia. ReAlta was initially formed as a joint venture between Children’s Hospital of The King’s Daughters, Children’s Specialty Group (170 multispecialty pediatricians) and Eastern Virginia Medical School. ReAlta is dedicated to addressing life-threatening medical needs through beneficial inhibition of the Complement System and Inflammatory Mechanisms. To support this mission, ReAlta has developed a New Class of Drugs that can address unmet medical needs through unique Multi-Modal Therapeutic Capabilities.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Company Profile for Sylabs Inc.

Posted by fidest press agency su venerdì, 23 agosto 2019

After its initial release in 2016, Singularity was immediately accepted by the research community to meet scientists’ demands for a new application packaging methodology through containers. Today, Singularity is deployed on many of the largest supercomputers in the world.Developed specifically for HPC, Singularity’s success is firmly rooted in the open source community. Singularity is considered the platform of choice by academia and commercial HPC centers. The features that make Singularity popular with HPC users also make it the ideal container technology for data-intensive workloads, or what is characterized as Enterprise Performance Computing (EPC).As today’s enterprises leverage more data to support and grow their businesses, the need to properly containerize and support workflows related to artificial intelligence, machine/deep learning, and advanced analytics has grown substantially. Sylabs was founded to solve this challenge by enhancing the free Community version to create SingularityPRO, a commercially supported enterprise version of Singularity.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Company Profile for Keane

Posted by fidest press agency su domenica, 4 agosto 2019

Keane provides unclaimed property compliance, consulting, asset reunification and reporting services worldwide. We assist Fortune 500 companies, law firms, accounting firms, universities, small businesses and consumers with their unclaimed property needs while mitigating risks, reducing costs, and retaining more customers and accounts. By Federal and State laws, corporations are required to locate owners who may be unaware, or lost track, of the asset they own. Keane’s expertise allows for this location before or after assets are transferred to the states. Our business model is founded on, and governed by, state mandated laws and principles.
Founded in 1949, Keane began by assisting financial institutions with locating account owners and reuniting assets. Our name originated from the radio show Mr. Keene, Tracer of Lost Persons which ran from 1937 to 1955. Keane has historically served as a pioneer in molding the unclaimed property industry. Keane’s founder participated in formulating The Uniform Unclaimed Property Act of 1954 which initiated a new landscape of unclaimed property enforcement across the country. As a result, we expanded our service reach and national footprint. Keane also influenced the Uniform Unclaimed Property Act of 1995, and in 1997 the Securities and Exchange Commission (SEC) called on Keane to provide testimony and assist in drafting the SEC Rule: 17Ad-17. During the 2000’s, Keane continued as the premier unclaimed property provider and further expanded our expertise by combining the top three independent firms in the industry. What sets Keane apart is our total commitment to customer service, the expertise and qualifications of our employees, and our demonstrated accountability for measurable results. Today, Keane assists our consumer clients by identifying and reuniting them with their assets to which they are entitled. Keane is also privileged to help our corporate clients maintain compliance, minimize risk, retain assets, and comply with state and federal annual reporting regulations.

Posted in Estero/world news, Uncategorized | Contrassegnato da tag: , , | Leave a Comment »

Company Profile for Masimo

Posted by fidest press agency su lunedì, 15 luglio 2019

Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve patient outcomes and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies. Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates, improve CCHD screening in newborns, and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs. Masimo SET® is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world, and is the primary pulse oximetry at 9 of the top 10 hospitals listed in the 2018-19 U.S. News and World Report Best Hospitals Honor Roll. Masimo continues to refine SET® and in 2018, announced that SpO2 accuracy on RD SET™ sensors during conditions of motion has been significantly improved, providing clinicians with even greater confidence that the SpO2 values they rely on accurately reflect a patient’s physiological status. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7® and Radius™ PPG, portable devices like Rad-67™, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97™. Masimo hospital automation and connectivity solutions are centered around the Iris® platform, and include Iris Gateway™, Patient SafetyNet, Replica™, Halo ION™, UniView™, and Doctella™.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Company Profile for Novus Therapeutics, Inc.

Posted by fidest press agency su mercoledì, 20 febbraio 2019

Novus Therapeutics, Inc. (“Novus”) is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”). Novus has two technologies, each that has the potential to be developed for multiple ENT indications. Novus’ lead product candidate (OP0201) is a surfactant-based, drug-device combination product being developed as a potential first-in-class treatment option for patients at risk for, or with, otitis media (“OM” or middle ear inflammation with or without infection). Globally, OM affects more than 700 million adults and children every year, with over half of the cases occurring in children under five years of age. OM is one of the most common disorders seen in pediatric practice, and in the United States is a leading cause of health care visits and the most frequent reason children are prescribed antibiotics or undergo surgery. Novus also has a foam-based drug delivery technology (OP0102), which may be developed in the future to deliver drugs into the ear, nasal, and sinus cavities. For more information please visit novustherapeutics.com.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Company Profile for Perficient

Posted by fidest press agency su martedì, 21 agosto 2018

Perficient is the leading digital transformation consulting firm serving Global 2000® and enterprise customers throughout North America. With unparalleled information technology, management consulting, and creative capabilities, Perficient and its Perficient Digital agency deliver vision, execution, and value with outstanding digital experience, business optimization, and industry solutions. Our work enables clients to improve productivity and competitiveness; grow and strengthen relationships with customers, suppliers, and partners; and reduce costs. Perficient’s professionals serve clients from a network of offices across North America and offshore locations in India and China. Traded on the Nasdaq Global Select Market, Perficient is a member of the Russell 2000 index and the S&P SmallCap 600 index. Perficient is an award-winning Platinum Level IBM business partner, a Microsoft National Service Provider and Gold Certified Partner, an Oracle Platinum Partner, an Adobe Premier Partner, and a Gold Salesforce Consulting Partner. http://www.perficient.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Mohsen has won the 2009 Freedom

Posted by fidest press agency su martedì, 1 dicembre 2009

London: Mohsen Makhmalbaf, the celebrated Iranian filmmaker and official overseas spokesman for 2009 Iranian presidential candidate Mir-Hossein Mousavi, has won the 2009 Freedom to Create Prize. The only prize of its kind, the Freedom to Create Prize celebrates the use of the arts to drive change and build the foundations of creativity in broken societies. Bianca Jagger, Founder and Chair of the Bianca Jagger Human Rights Foundation, presented Mr Makhmalbaf with his award at a high profile London ceremony at the Victoria & Albert Museum on 25 November 2009. Mohsen Makhmalbaf has dedicated his award to Iran’s Green Movement and its spiritual leader, Grand Ayatollah Hossein-Ali Montazeri. Commenting on his award, Makhmalbaf said, “People of my country (Iran) are killed, imprisoned, tortured and raped just for their votes. Every award I receive means an opportunity for me to echo their voices to the world, asking for democracy for Iran and peace for the world.” The second place prize winner is Burmese refugee women’s group, The Kumjing Storytellers, who use giant paper maché dolls to represent their stories of ethnic persecution in Burma and the plight of migrants and refugees from around the world. The third place prize winner is Afghan female artist Sheenkai Alam Stanikzai, who uses video performance, installation and photography to tackle the subjugation and violent persecution of women in Afghanistan and neighbouring countries. Prize founder and Chairman of Orient Global Richard F. Chandler said he was humbled by the bravery of this year’s winners adding their courage and stories epitomised the daily sacrifices made by artists on frontlines from around the world. Freedom to Create is an initiative that seeks to improve lives by addressing society’s ability to support and sustain creativity. The initiative focuses on those societies in greatest need.(Mohsen Makhmalbaf)

Posted in Estero/world news, Mostre - Spettacoli/Exhibitions – Theatre | Contrassegnato da tag: , , , | Leave a Comment »